We are live on
!
Find out more
Charles River Laboratories
CRL
CRL
633 hedge funds and large institutions have $12.4B invested in Charles River Laboratories in 2023 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 204 increasing their positions, 258 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
167% more funds holding in top 10
Funds holding in top 10: 3 → 8 (+5)
34% more first-time investments, than exits
New positions opened: 94 | Existing positions closed: 70
22% more capital invested
Capital invested by funds: $10.1B → $12.4B (+$2.25B)
2% more funds holding
Funds holding: 621 → 633 (+12)
1.21% more ownership
Funds ownership: 101.05% → 102.25% (+1.2%)
21% less repeat investments, than reductions
Existing positions increased: 204 | Existing positions reduced: 258
32% less call options, than puts
Call options by funds: $54.7M | Put options by funds: $80.5M
Holders
633
Holders Change
+12
Holders Change %
+1.93%
% of All Funds
9.23%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.12%
New
94
Increased
204
Reduced
258
Closed
70
Calls
$54.7M
Puts
$80.5M
Net Calls
-$25.8M
Net Calls Change
-$3.78M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$82.4M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$80.4M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$60.5M |
| 4 |
MG
Meritage Group
San Francisco,
California
|
+$53.4M |
| 5 |
SCA
Southpoint Capital Advisors
New York
|
+$39.3M |
